跳至主要内容
临床试验/NL-OMON51912
NL-OMON51912尚未招募不适用

Towards Response guided ADAptive Radiotherapy for organ preserving treatment of intermediate risk rectal cancer: a phase I dose finding trial - preRADAR

niversitair Medisch Centrum Utrecht0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • primary intermediate risk rectal adenocarcinoma, fit for multimodal treatment

排除标准

  • contra-indication for magnetic resonance-guided treatment or for pelvic
  • radiotherapy (such as inflammatory bowel disease, prior pelvic radiotherapy,
  • pregnancy, hip implants)

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

招募中
不适用
Towards Response guided ADAptive Radiotherapy for organ preserving treatment of intermediate risk rectal cancer: a phase I dose finding trialrectal cancer
NL-OMON22916MC Utrecht45
招募中
Unknown
Prospective validation of Adaptive Radiotherapy in patients with head and neck tumorsHead- and Neckregion, C00-C14, C40-44, C73-C97C00-C14C40-C41C43-C44C73-C75C76-C80C81-C96C97Malignant neoplasms of lip, oral cavity and pharynxMalignant neoplasms of bone and articular cartilageMelanoma and other malignant neoplasms of skinMalignant neoplasms of thyroid and other endocrine glandsMalignant neoplasms of ill-defined, secondary and unspecified sitesMalignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissueMalignant neoplasms of independent (primary) multiple sites
DRKS00033144Klinik für Strahlentherapie, Universitätsklinikum Essen, NCT West30
尚未招募
2 期
Phase II study: Response adapted radiation therapy after induction chemotherapy in stage II-IVA nasopharyngeal carcinomaDue to the reports of radiation dose reduction in clinical response to induction chemotherapy of NPC patients are scarce. Therefore&#44We propose a phase II study to evaluate efficacy and feasibility ofnasopharyngeal carcinoma &#44induction chemotherapy &#44EBV DNA viral load
TCTR20180831004one138
尚未招募
2 期
Adaptive Radiotherapy for Head and Neck Cancer: Feasibility and Clinical ImplicationsHead and Neck CancerCancer - Head and neck
ACTRN12615000771550Susan Mincham20
招募中
不适用
RADprecise - Personalized radiotherapy: incorporating cellular response to irradiation in personalized treatment planning to minimize radiation toxicityC50C61Malignant neoplasm of breastMalignant neoplasm of prostate
DRKS00020290Deutsches Krebsforschungszentrum (DKFZ) / German Cancer Research Center1,050
Towards Response guided ADAptive Radiotherapy for... | 临床试验